The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines
1h Free Analyst Time
The human vaccine market is poised to grow by $20.37 billion during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines.
The human vaccine market analysis includes the route of administration segment and geographic landscape.
The human vaccine market is segmented as below:
By Route of Administration
- Intramuscular
- Subcutaneous
- Oral
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:
- Human vaccine market sizing
- Human vaccine market forecast
- Human vaccine market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Route of Administration
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global human vaccine market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Sanofi, and Serum Institute of India Pvt. Ltd.Commenting on the report, an analyst said: ''The latest trend gaining momentum in the market is varied demand for vaccines in high-income and developing countries.''
According to the report, one of the major drivers for this market is the increase in investments in vaccines segment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Astellas Pharma Inc.
- AstraZeneca PLC
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- BioNTech SE
- CanSino Biologics Inc.
- CSL Ltd.
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- GlaxoSmithKline PLC
- Gradalis Inc.
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson
- Merck and Co. Inc.
- Mitsubishi Chemical Holdings Corp.
- Moderna Inc.
- Novavax Inc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.